-+ 0.00%
-+ 0.00%
-+ 0.00%

Bausch Health Q2 FY26 GAAP net income rises 74% to $258 million; revenue increases 13% to $2.85 billion

PUBT·07/29/2026 20:24:45
Listen to the news
Bausch Health Q2 FY26 GAAP net income rises 74% to $258 million; revenue increases 13% to $2.85 billion
  • Bausch Health posted Q2 2026 GAAP net income attributable to shareholders of USD 258 million, lifting diluted GAAP EPS to USD 0.68.
  • Revenue rose 13% from a year earlier to USD 2.85 billion; consolidated operating income climbed to USD 740 million.
  • Consolidated adjusted EBITDA attributable to shareholders (non-GAAP) increased 28% to USD 1.08 billion.
  • Management cited a thirteenth straight quarter of year-over-year revenue and adjusted EBITDA growth excluding Bausch + Lomb, with net debt reduced.
  • 2026 revenue guidance increased to USD 10.79 billion–USD 11.04 billion; adjusted EBITDA (non-GAAP) lifted to USD 4.05 billion–USD 4.18 billion.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bausch Health Companies Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: NY14836) on July 29, 2026, and is solely responsible for the information contained therein.